Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data

The involvement of viruses and SARS-CoV-2 in autoimmune diseases is well known. The recent demonstration that ChAdOx1 nCoV-19 Covid-19 (AstraZeneca) vaccine (ChA) favors the production of anti-platelet factor 4 (anti-PF4) antibodies, blood clots, and thrombocytopenia raises the question of whether o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cari, Luigi, Fiore, Paolo, Naghavi Alhosseini, Mahdieh, Sava, Gianni, Nocentini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220408/
https://www.ncbi.nlm.nih.gov/pubmed/34174723
http://dx.doi.org/10.1016/j.jaut.2021.102685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220408/
https://www.ncbi.nlm.nih.gov/pubmed/34174723
http://dx.doi.org/10.1016/j.jaut.2021.102685

Ejemplares similares